Pierre A. Morgon is Chief Executive Officer of MRGN Advisors and Adviser to the Board of The Chalfont Project. He is also Regional Partner for Switzerland at Mérieux Développement, Chairman of the Board of Virometix, Non-Executive Director to the Board of Theradiag and Non-Executive Director to the Board of Eurocine Vaccines. He holds a Doctorate of Pharmacy, a Masters in Business Law and a MBA. He is also an alumnus of INSEAD, IMD and the MCE executive programs. Pierre has over 30 years of experience in the global life science industry and in healthcare information technology. Through these local and global positions, he has acquired direct experience with leading multi-cultural teams, driving corporate transformations and leading partnerships and integration of acquisitions in diverse markets, geographies and organizations. He also brings the perspective of the investor and of the shareholder in driving value growth through high performance organizations.